Abstract
Fragile X syndrome has been recognized as the second most common cause of mental retardation after Down's syndrome, and has been diagnosed by cytogenetic and molecular analyses. Results from cytogenetic and molecular studies by Polymerase Chain Reaction (PCR) techniques in 34 patients suspected of fragile X syndrome (FRAXA) are compared. Results were similar: in five patients with karyotype 46,Yfra(X)(q27.3) the PCR technique also revealed mutation of FMR1 gene. In the other 29 patients who failed to express fragile X chromosome, PCR technique also showed the absence of mutation of FMR1 gene. Although PCR technique guaranteed fast FRAXA search, the cytogenetic study was as efficient as the PCR technique to diagnose fragile chromosome X syndrome in mentally retarded subjects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
